Patent · US Active

Treatment of conditions relating to hormone deficiencies by administration of progestins

US8076319B2 · kind B2 · utility

52Cited by
10References
9Claims
0Family size

Assignee

Inventor

Key dates

Filing dateFeb 4, 2010
Grant dateDec 13, 2011
Priority date
Expiry dateFeb 18, 2030

Classification

  • Technology area (CPC A)Human Necessities
  • CPC primaryA61P15/12
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

The present invention includes methods for preventing endometrial hyperplasia associated with estrogen therapy through the administration of a progestin agent. The methods presented may include starting the administration of a progestin agent at a high dose, and then lowering the dose.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.